Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Procrit
Procrit
Pfizer launches biosimilar version of Amgen's Epogen
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
Flag link:
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
Fierce Pharma
FDA
advisory panels
Pfizer
biosimilars
Amgen
Epogen
Procrit
anemia
JNJ
Flag link:
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Fierce Pharma
Amgen
Epogen
anemia
Procrit
JNJ
Flag link:
Is Johnson & Johnson Heading Off The Patent Cliff?
Is Johnson & Johnson Heading Off The Patent Cliff?
Seeking Alpha
JNJ
patent cliff
Novartis
Pfizer
Aciphex
Procrit
Velcade
Remicade
Flag link:
EPO Pills: A Challenge For Amgen And Johnson & Johnson
EPO Pills: A Challenge For Amgen And Johnson & Johnson
Seeking Alpha
JNJ
Amgen
Aranesp
Procrit
Epogen
Flag link:
FDA recommends lower doses of anemia drugs
FDA recommends lower doses of anemia drugs
Yahoo/AP
Aranesp
Procrit
Epogen
chronic kidney disease
Flag link:
Amgen, J&J Anemia Drugs Won’t Face New U.S. Coverage Policy
Amgen, J&J Anemia Drugs Won’t Face New U.S. Coverage Policy
Bloomberg
Amgen
JNJ
Epogen
Procrit
Aranesp
anemia
Flag link:
Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Bloomberg
Amgen
Epogen
JNJ
Procrit
anemia
Flag link:
Analysts say current Medicare policy on anemia drugs is best scenario for Amgen
Analysts say current Medicare policy on anemia drugs is best scenario for Amgen
Yahoo/AP
Medicare
anemia
Amgen
JNJ
Procrit
Aranesp
Epogen
Flag link:
Amgen Rises On Medicare’s Decision Not To Decide
Amgen Rises On Medicare’s Decision Not To Decide
Forbes
Medicare
Amgen
anemia
Aranesp
Procrit
JNJ
Flag link:
FDA may limit anemia drug use for kidney disease
FDA may limit anemia drug use for kidney disease
Yahoo/AP
anemia
kidney disease
FDA
Amgen
Procrit
Aranesp
Epogen
Flag link:
Amgen recalls anemia drugs due to glass flakes
Amgen recalls anemia drugs due to glass flakes
Yahoo/AP
Amgen
anemia
recalls
Epogen
Procrit
Flag link:
J&J on Hook for "Hundreds of Millions" Over Technicality in Anemia Drug Case
J&J on Hook for "Hundreds of Millions" Over Technicality in Anemia Drug Case
BNET Pharma
anemia
JNJ
Procrit
Ortho Biotech
Flag link:
Medicare mulls new restrictions on anemia meds
Medicare mulls new restrictions on anemia meds
Fierce Pharma
Medicare
anemia
JNJ
Epogen
Procrit
Amgen
Aranesp
Flag link:
FDA asks Amgen, J&J to discuss anemia drug risks
FDA asks Amgen, J&J to discuss anemia drug risks
Yahoo/AP
JNJ
Amgen
FDA
anemia
Aranesp
Procrit
Epogen
Flag link:
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Bloomberg
FDA
anemia
Amgen
Aranesp
Epogen
Procrit
JNJ
Flag link:
Study confirms clot risks with anti-anemia drugs
Study confirms clot risks with anti-anemia drugs
Reuters
anemia
cancer
Amgen
Aranesp
Epogen
Procrit
JNJ
Flag link:
Drug Rep in $3B Procrit Case: "80% of My Sales Were Medicare Fraud"; Carried $400K in "Cash"
Drug Rep in $3B Procrit Case: "80% of My Sales Were Medicare Fraud"; Carried $400K in "Cash"
BNET Pharma
drug reps
whistleblowers
Procrit
Medicare fraud
Medicare
Ortho Biotech
JNJ
Flag link: